Delivery Order SPE2DB22D2006-SPE2DB24FW0NF
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,140.05 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in quantities of 30. The contract has an ultimate completion date of October 26, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,264.96 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.43 firm fixed-price delivery order is for the supply of 4 mg Ondansetron orally disintegrating tablets. The award is not designated under any set-aside program. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,828.36 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCl tablets. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is a $27,199.78 Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages, with a performance period through January 8, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,643.99 firm fixed-price delivery order contract is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The contract has an ultimate completion date of May 28, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,805.20 firm fixed-price delivery order is for the supply of 4 mg ondansetron orally disintegrating tablets. The contract has a completion date of November 14, 2024 and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,605.34 firm-fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which covers a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,999.76 firm fixed-price delivery order is for the supply of 4 mg Ondansetron orally disintegrating tablets. The contract has an ultimate completion date of April 2, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,067.40 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets (ODT) in 30-count packages. The contract has a period of performance through February 16, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FW0NFDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,790.90 firm fixed-price delivery order is for the supply of 4 mg Ondansetron Orally Disintegrating Tablets to support federal healthcare programs. The contract is not designated with a set-aside requirement, indicating open competition. It is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/21/24 |